Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.
Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...
Rowell v. City Of New York et al. Date: September 28, 2018. Docket Number: 1: 2016cv06598. Grewal v. Cuneo et ... Joint Stock Company Channel One Russia Worldwide et al v. Infomir LLC et al .... et al v. Taro Pharmaceutical Industries, Ltd. et al .... LLC v. Columbia Properties Phoenix, L.P. et al ...... Inc. v. AstraZeneca plc
Aug 31, 2011 ... noting that appellants' failure to cite to the place in the record where they objected to trial court's ruling results in waiver. ... numerous pharmaceutical companies, including defendant Johnson ..... 156 (1st Cir.2009), cert. dismissed sub. nom., AstraZeneca Pharm. LP v. ...... Alpharma USPD, Inc. et al., No.
LP, Case No. 2011-1091 (Fed. ... Pannu v. Iolab, 47 U.S.P.Q. 2d 1657 (Fed. Cir. 1998). Hess v. ACS, 41 U.S.P.Q. 2d 1782 (Fed. Cir. 1997). Fina v. ... In re Kaplan et al., 229 U.S.P.Q. 678 (Fed. Cir. 1986) ... In re Metoprolol Succinate Patent Litigation (AstraZeneca v. KV Pharmaceutical), 83 U.S.P.Q. 2d 1545 (Fed. Cir. 2007).
Jan 25, 2018 ... ASTRAZENECA PHARMACEUTICALS LP, ET AL., ... YORK v. BRISTOL!MYERS SQUIBB COMPANY, ET AL., C.A. No. ..... HESS v. FORD MOTOR COMPANY, C.A. No. 5:17!05996. ROMERO, ET ..... Pharmaceuticals Corp., to transfer of their respective following ... PURDUE PHARMA L.P., ET AL., C.A. No.
Aug 10, 2010 ... Served on the advisory board for: AstraZeneca Pharmaceuticals LP; ... of Cancer Research and AstraZeneca Rewards to Inventors Scheme.
Arrowhead Pharmaceutical's $670 million licensing & collaboration agreement with ..... "The record, however, reflects a pervasive pattern of misconduct by Merck and its ... GlaxoSmithKline LLC et al v Teva Pharmaceuticals USA Inc ..... patent cases that AstraZeneca had brought to enforce its patents for Nexium, a widely ...